Neuroscience and digital-health company developing eye-tracking and AI tools for neurodevelopmental and neurocognitive care. BGaze Clinic measures small involuntary eye movements, called cognitive vergence, to support clinicians assessing ADHD; BGaze Focus uses gaze-controlled games for attention training through clinicians and therapists. Its research pipeline also covers autism, dyslexia and Alzheimer’s disease; these pipeline applications are not described as approved treatments. Founded in 2013 as a University of Barcelona spinout, it operates in the UK and Barcelona.
